Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Job Description A 2-year Postdoc in Runtime Analysis and Configuration of Time-Sensitive Networking (TSN) for In-Vehicle Networks is available in the Embedded Systems Engineering (ESE) section
-
Job Description A 2-year Postdoc in Secure Task Offloading for Software Defined Vehicles (SDV) is available in the Embedded Systems Engineering (ESE) section at DTU Compute. The position is part of
-
AI Strategy and is carried out in collaboration with major Danish universities, including the University of Copenhagen, the University of Southern Denmark, and the Alexandra Institute. Place of work
-
AI Strategy and is carried out in collaboration with major Danish universities, including the University of Copenhagen, the University of Southern Denmark, and the Alexandra Institute. Place of work
-
prototyping for sensor or device development. Electronics and embedded systems using open-source hardware. Microcontroller programming and data analysis (e.g., using Python); experience in continuous signal
-
Postdoc position in Materials Characterization for Additive/Subtractive Manufacturing and Sustain...
Interfaces in Additive/Subtractive Hybrid Manufacturing for Sustainable Refurbishment. This position is part of the CiP (Circularity in Production), which aims to develop and demonstrate hybrid manufacturing
-
Interfaces in Additive/Subtractive Hybrid Manufacturing for Sustainable Refurbishment. This position is part of the CiP (Circularity in Production), which aims to develop and demonstrate hybrid manufacturing
-
11 Mar 2025 Job Information Organisation/Company Technical University Of Denmark Department DTU Bioengineering Research Field Biological sciences » Biological engineering Medical sciences » Cancer
-
A 3-year Postdoc position for an experienced is available within the research group ‘Biotherapeutic Glycoengineering and Immunology’ headed by Professor Steffen Goletz and is funded by a NNF
-
Job Description A 3-year Postdoc position for an experienced is available within the research group ‘Biotherapeutic Glycoengineering and Immunology’ headed by Professor Steffen Goletz and is funded